SUN© is the pharmaceutical division of Valance Inc.©. It specializes in redesigning the human DNA, creating a new and better version of humankind for both ourselves and the Earth.  It is responsible for discovering the new, exciting and promising cellular used for Bio Fusion©. SUN© is vital to Valance Inc.© because it also creates and provides the necessary nutritional supplements needed to both grow and sustain Bio Fusion© products.




S.U.N. Pharmaceuticals scans the length of the Earth to employ the most talented researchers who are all at the top of their respective fields. We invest in the most current state-of-the-art technology and are dedicated to developing various ways to improve human life. Through groundbreaking science, we have reached a pinnacle never before seen in the history of mankind.

Through extensive research in cellular structure, DNA manipulation and replication, and cell graphing we are the sole provider of Valance Inc.’s matrix systems. These intricate yet functional grids are developed to provide innovative and customizable environments while redefining and enhancing the human experience.


In 2014 a total of $2.7 million was spent on research and development. We are committed to increasing spending with each and every year. We have over 8,000 

employees working in research and development worldwide.


S.U.N. Pharmaceuticals is the only company simultaneously researching improvements in the quality of our environment and that of human life. Structured and thorough analysis from our scientists and Valance Inc.’s research provides the momentum for collaborating on projects such as the Bio Fusion series.


Biology and technology are the platforms in which we are building upon our future. Our commitment is to always provide the most advanced technological development for a more sustainable and ecologically sound future.

reasearch and


Healthcare 68%

Matrix Science 26%

Biotech Advancement 4%

Reconciliation 2%

Total Sales